{"id":253015,"date":"2025-10-31T10:45:08","date_gmt":"2025-10-31T10:45:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/253015\/"},"modified":"2025-10-31T10:45:08","modified_gmt":"2025-10-31T10:45:08","slug":"antiviral-candidates-for-enterovirus-71-targeting-viral-proteome-and-stage-specific-lifecycle-interventions-virology-journal","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/253015\/","title":{"rendered":"Antiviral candidates for enterovirus 71: targeting viral proteome and stage-specific lifecycle interventions | Virology Journal"},"content":{"rendered":"

Pallansch MA, Oberste MS, Whitton J. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, editors. Fields Virology. Vol. 1; 6th ed. Lippincott Williams & Wilkins: Philadelphia, PA, USA; 2013. pp. 490\u2013530.<\/p>\n

Stanway G. Structure, function and evolution of picornaviruses. J Gen Virol. 1990;71:2483\u2013501.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Majumdar M, Sharif S, Klapsa D, Wilton T, Alam MM, Fernandez-Garcia MD, et al. Environmental surveillance reveals complex enterovirus circulation patterns in human populations. Open Forum Infect Dis. 2018;5:ofy250.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhou J, Shi Y, Miao L, Zhang C, Liu Y. Molecular epidemiology and recombination of enterovirus A71 in mainland China from 1987 to 2017. Int Microbiol. 2021;24:291\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

van der Sanden S, Koopmans M, Uslu G, van der Avoort H, Dutch working group for clinical Virology. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J Clin Microbiol. 2009;47:2826\u201333.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chang L-Y, Lin H-Y, Gau SS-F, Lu C-Y, Hsia S-H, Huang Y-C, et al. Enterovirus A71 neurologic complications and long-term sequelae. J Biomed Sci. 2019;26:57.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097\u2013105.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xiao J, Huang K, Lu H, Song Y, Han Z, Zhang M, et al. Genomic epidemiology and phylodynamic analysis of enterovirus A71 reveal its transmission dynamics in Asia. Microbiol Spectr. 2022;10:e01958\u201322.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26:75.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ooi MH, Wong SC, Podin Y, Akin W, del Sel S, Mohan A, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44:646\u201356.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Takahashi S, Liao Q, Van Boeckel TP, Xing W, Sun J, Hsiao VY, et al. Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Med. 2016;13:e1001958.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang B, Liu F, Liao Q, Wu P, Chang Z, Huang J, et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017;22:16\u201300824.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nayak G, Bhuyan SK, Bhuyan R, Sahu A, Kar D, Kuanar A. Global emergence of enterovirus 71: a systematic review. Beni-Suef Univ J Basic Appl Sci. 2022;11:78.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hassel C, Mirand A, Lukashev A, TerletskaiaLadwig E, Farkas A, Schuffenecker I, et al. Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. Euro Surveill. 2015;20:30005.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhao J, Li X. Determinants of the transmission variation of hand, foot and mouth disease in China. PLoS ONE. 2016;11:e0163789.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ghosh S, Kumar M, Santiana M, Mishra A, Zhang M, Labayo H, et al. Enteric viruses replicate in salivary glands and infect through saliva. Nature. 2022;607:345\u201350.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chen Y-J, Meng F-Y, Mao Q, Li J-X, Wang H, Liang Z-L, et al. Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial. Hum Vaccin Immunother. 2014;10:1366\u201372.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829\u201337.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818\u201328.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Steil BP, Barton DJ. Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Res. 2009;139:240\u201352.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lozano G, Mart\u00ednez-Salas E. Structural insights into viral IRES-dependent translation mechanisms. Curr Opin Virol. 2015;12:113\u201320.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin J-Y, Chen T-C, Weng K-F, Chang S-C, Chen L-L, Shih S-R. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci. 2009;16:103.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ke Y-Y, Chen Y-C, Lin T-H. Structure of the virus capsid protein VP1 of enterovirus 71 predicted by some homology modeling and molecular docking studies. J Comput Chem. 2006;27:1556\u201370.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li C, Wang H, Shih S-R, Chen T-C, Li M-L. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. Curr Med Chem. 2007;14:847\u201356.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kiener TK, Jia Q, Lim XF, He F, Meng T, Kwong Chow VT, et al. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J. 2012;9:55.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Jia Q, Ng Q, Chin W, Meng T, Chow VTK, Wang C-I, et al. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity. Sci Rep. 2017;7:46402.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cao J, Qu M, Liu H, Wan X, Li F, Hou A, et al. Myristoylation of EV71 VP4 is essential for infectivity and interaction with membrane structure. Virol Sin. 2020;35(5):599\u2013613.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang X, Aloise C, van Vliet ALW, Zwaagstra M, Lyoo H, Cheng A, et al. Proteolytic activities of enterovirus 2A do not depend on its interaction with SETD3. Viruses. 2022;14:1360.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mu Z, Wang B, Zhang X, Gao X, Qin B, Zhao Z, et al. Crystal structure of 2A proteinase from Hand, foot and mouth disease virus. J Mol Biol. 2013;425:4530\u201343.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xie S, Wang K, Yu W, Lu W, Xu K, Wang J, et al. DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71. Cell Res. 2011;21:1271\u20135.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Guan H, Tian J, Qin B, Wojdyla JA, Wang B, Zhao Z, et al. Crystal structure of 2 c helicase from enterovirus 71. Sci Adv. 2017;3:e1602573.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Liu Y, Lv P, Wang W, Zhang J, Zhou X, Qiu Y et al. Structural insight into EV-A71 3A protein and its interaction with a peptide inhibitor. Virol Sin. 2023;S1995-820X(23)00112-8.<\/p>\n

Chen C, Wang Y, Shan C, Sun Y, Xu P, Zhou H, et al. Crystal structure of enterovirus 71 RNA-dependent RNA polymerase complexed with its protein primer vpg: implication for a trans mechanism of VPg uridylylation. J Virol. 2013;87:5755\u201368.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wen W, Qi Z, Wang J. The function and mechanism of enterovirus 71 (EV71) 3 c protease. Curr Microbiol. 2020;77:1968\u201375.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang L-C, Chen S-O, Chang S-P, Lee Y-P, Yu C-K, Chen C-L, et al. Enterovirus 71 proteins 2A and 3D antagonize the antiviral activity of gamma interferon via signaling attenuation. J Virol. 2015;89:7028\u201337.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195\u2013205.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336:1274.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Shih SR, Li YS, Chiou CC, Suen PC, Lin TY, Chang LY, et al. Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J Med Virol. 2000;61:228\u201334.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A. 2013;110:5463\u20137.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985;317:145\u201353.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rossmann MG, He Y, Kuhn RJ. Picornavirus-receptor interactions. Trends Microbiol. 2002;10:324\u201331.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cai Q, Yameen M, Liu W, Gao Z, Li Y, Peng X, et al. Conformational plasticity of the 2A proteinase from enterovirus 71. J Virol. 2013;87:7348\u201356.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mj HT, Mg N, Cw M, Jj A, Fw D et al. S,. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell [Internet]. 1986 [cited 2024 Jun 2];45. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/3011278\/<\/a><\/p>\n

Hwang Y-C, Chen W, Yates MV. Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo. Appl Environ Microbiol. 2006;72:3710\u20135.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Supasorn O, Tongtawe P, Srimanote P, Rattanakomol P, Thanongsaksrikul J. A nonstructural 2B protein of enterovirus A71 increases cytosolic Ca2\u2009+\u2009and induces apoptosis in human neuroblastoma SH-SY5Y cells. J Neurovirol. 2020;26:201\u201313.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tang W-F, Yang S-Y, Wu B-W, Jheng J-R, Chen Y-L, Shih C-H, et al. Reticulon 3 binds the 2 C protein of enterovirus 71 and is required for viral replication. J Biol Chem. 2007;282:5888\u201398.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xiao X, Lei X, Zhang Z, Ma Y, Qi J, Wu C, et al. Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4-kinase III\u03b2-ACBD3 interaction. J Virol. 2017;91:e00791-17.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nagy PD, Strating JRPM, van Kuppeveld FJM. Building viral replication organelles: close encounters of the membrane types. PLoS Pathog. 2016;12:e1005912.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sasaki J, Ishikawa K, Arita M, Taniguchi K. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 2012;31:754\u201366.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chalupska D, R\u00f3\u017cycki B, Humpolickova J, Faltova L, Klima M, Boura E. Phosphatidylinositol 4-kinase III\u03b2 (PI4KB) forms highly flexible heterocomplexes that include ACBD3, 14-3-3, and Rab11 proteins. Sci Rep. 2019;9:567.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Horova V, Lyoo H, R\u00f3\u017cycki B, Chalupska D, Smola M, Humpolickova J, et al. Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites. PLoS Pathog. 2019;15:e1007962.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Klima M, T\u00f3th DJ, Hexnerova R, Baumlova A, Chalupska D, Tykvart J, et al. Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein. Sci Rep. 2016;6:23641.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tan YW, Yam WK, Kooi RJW, Westman J, Arbrandt G, Chu JJH. Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition. Sci Rep-uk. 2021;11:9719.<\/p>\n

CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cui S, Wang J, Fan T, Qin B, Guo L, Lei X, et al. Crystal structure of human enterovirus 71 3 C protease. J Mol Biol. 2011;408:449\u201361.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dougherty WG, Semler BL. Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev. 1993;57:781\u2013822.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kusov YY, Gauss-M\u00fcller V. In vitro RNA binding of the hepatitis A virus proteinase 3 C (HAV 3Cpro) to secondary structure elements within the 5\u2019 terminus of the HAV genome. RNA. 1997;3:291\u2013302.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mondal S, Sarvari G, Boehr DD. Picornavirus 3 c proteins intervene in host cell processes through proteolysis and interactions with RNA. Viruses. 2023;15:2413.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ferrer-Orta C, Ferrero DS, Verdaguer N. Dual role of the foot-and-mouth disease virus 3B1 protein in the replication complex: as protein primer and as an essential component to recruit 3Dpol to membranes. PLoS Pathog. 2023;19:e1011373.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang J, Ptacek JB, Kirkegaard K, Bullitt E. Double-membraned liposomes sculpted by poliovirus 3AB protein. J Biol Chem. 2013;288:27287\u201398.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J et al. Enterovirus A71 Proteins: Structure and Function. Front Microbiol [Internet]. 2018 [cited 2025 Feb 16];9. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/<\/a>https:\/\/doi.org\/10.3389\/fmicb.2018.00286\/full<\/a><\/p>\n

Durk RC, Singh K, Cornelison CA, Rai DK, Matzek KB, Leslie MD, et al. Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymerase. PLoS ONE. 2010;5:e15049.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nie Z, Zhai F, Zhang H, Zheng H, Pei J. The multiple roles of viral 3Dpol protein in picornavirus infections. Virulence. 2024;15:2333562.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798\u2013801.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15:794\u20137.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009;6:141.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang S-L, Chou Y-T, Wu C-N, Ho M-S. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85:11809\u201320.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tan CW, Poh CL, Sam I-C, Chan YF. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol. 2013;87:611\u201320.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012;86:5686\u201396.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol. 2012;19:424\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Panjwani A, Strauss M, Gold S, Wenham H, Jackson T, Chou JJ, et al. Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric pore. PLoS Pathog. 2014;10:e1004294.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hussain KM, Leong KLJ, Ng MM-L, Chu JJH. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem. 2011;286:309\u201321.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Liu Y, Sheng J, van Vliet ALW, Buda G, van Kuppeveld FJM, Rossmann MG. Molecular basis for the acid-initiated uncoating of human enterovirus D68. Proc Natl Acad Sci U S A. 2018;115:E12209\u201317.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kingston NJ, Snowden JS, Grehan K, Hall PK, Hietanen EV, Passchier TC, et al. Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate. PLoS Pathog. 2024;20:e1012511.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16:368\u201381.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Staring J, von Castelmur E, Blomen VA, van den Hengel LG, Brockmann M, Baggen J, et al. PLA2G16 represents a switch between entry and clearance of Picornaviridae. Nature. 2017;541:412\u20136.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Huang S-C, Chang C-L, Wang P-S, Tsai Y, Liu H-S. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J Med Virol. 2009;81:1241\u201352.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lai JKF, Sam I-C, Chan YF. The autophagic machinery in enterovirus infection. Viruses. 2016;8:32.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Miah M, Davis AM, Hannoun C, Said JS, Fitzek M, Preston M, et al. Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus. Antimicrob Agents Chemother. 2024;68:e0106423.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Huang Y-L, Huang S-W, Shen C-Y, Cheng D, Wang J-R. Conserved residues adjacent to \u00df-barrel and loop intersection among enterovirus VP1 affect viral replication: potential target for anti-enteroviral development. Viruses. 2022;14:364.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Huang Y-L, Lin T-M, Wang S-Y, Wang J-R. The role of conserved arginine and proline residues in enterovirus VP1 protein. J Microbiol Immunol Infect. 2022;55:590\u20137.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lalani S, Gew LT, Poh CL. Antiviral peptides against enterovirus A71 causing hand, foot and mouth disease. Peptides. 2021;136:170443.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin T-Y, Chu C, Chiu C-H. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J Infect Dis. 2002;186:1161\u20134.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Weng T-Y, Chen L-C, Shyu H-W, Chen S-H, Wang J-R, Yu C-K, et al. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antivir Res. 2005;67:31\u20137.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 2012;32:143\u201371.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Brice DC, Diamond G. Antiviral activities of human host defense peptides. Curr Med Chem. 2020;27:1420\u201343.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yu J, Dai Y, Fu Y, Wang K, Yang Y, Li M, et al. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding. Antivir Res. 2021;187:105021.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lai Z, Yuan X, Chen H, Zhu Y, Dong N, Shan A. Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability. Biotechnol Adv. 2022;59:107962.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Isogai E, Isogai H, Matuo K, Hirose K, Kowashi Y, Okumuara K, et al. Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues. Oral Microbiol Immunol. 2003;18:329\u201332.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Fan T, Liu B, Yao H, Chen X, Yang H, Guo S, et al. Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating. PLoS Pathog. 2024;20:e1011967.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tan CW, Chan YF, Sim KM, Tan EL, Poh CL. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS ONE. 2012;7:e34589.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Abd-Aziz N, Lee MF, Ong S-K, Poh CL. Antiviral activity of SP81 peptide against enterovirus A71 (EV-A71). Virology. 2024;589:109941.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, et al. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch Virol. 2012;157:669\u201379.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tijsma A, Franco D, Tucker S, Hilgenfeld R, Froeyen M, Leyssen P, et al. The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob Agents Chemother. 2014;58:6990\u20132.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rivero-Buceta E, Doyag\u00fcez EG, Colomer I, Quesada E, Mathys L, Noppen S, et al. Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41. Eur J Med Chem. 2015;106:34\u201343.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rivero-Buceta E, Sun L, Mart\u00ednez-Gualda B, Doyag\u00fcez EG, Donckers K, Quesada E, et al. Optimization of a class of tryptophan dendrimers that inhibit HIV replication leads to a selective, specific, and low-nanomolar inhibitor of clinical isolates of enterovirus A71. Antimicrob Agents Chemother. 2016;60:5064\u20137.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sun L, Lee H, Thibaut HJ, Lanko K, Rivero-Buceta E, Bator C, et al. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. PLoS Pathog. 2019;15:e1007760.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mart\u00ednez-Gualda B, Sun L, Mart\u00ed-Mar\u00ed O, Noppen S, Abdelnabi R, Bator CM, et al. Scaffold simplification strategy leads to a novel generation of dual human immunodeficiency virus and enterovirus-A71 entry inhibitors. J Med Chem. 2020;63:349\u201368.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mart\u00ed-Mar\u00ed O, Mart\u00ednez-Gualda B, de la Puente-Secades S, Mills A, Quesada E, Abdelnabi R, et al. Double arylation of the indole side chain of tri- and tetrapodal tryptophan derivatives renders highly potent HIV-1 and EV-A71 entry inhibitors\u2020. J Med Chem. 2021;64:10027\u201346.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ruiz-Santaquiteria M, Illescas BM, Abdelnabi R, Boonen A, Mills A, Mart\u00ed-Mar\u00ed O, et al. Multivalent tryptophan- and tyrosine-containing [60]fullerene hexa-adducts as dual HIV and enterovirus A71 entry inhibitors. Chemistry. 2021;27:10700\u201310.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mart\u00ed-Mar\u00ed O, Abdelnabi R, Schols D, Neyts J, Camarasa M-J, Gago F, et al. Insertion of an amphipathic linker in a tetrapodal tryptophan derivative leads to a novel and highly potent entry inhibitor of enterovirus A71 clinical isolates. Int J Mol Sci. 2023;24:3539.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lim TYM, Jaladanki CK, Wong YH, Yogarajah T, Fan H, Chu JJH. Tanomastat exerts multi-targeted inhibitory effects on viral capsid dissociation and RNA replication in human enteroviruses. EBioMedicine. 2024;107:105277.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hsieh C-F, Chen Y-L, Lin G-H, Chan YF, Hsieh P-W, Horng J-T. 3,4-dicaffeoylquinic acid from the medicinal plant Ilex kaushue disrupts the interaction between the five-fold axis of enterovirus A-71 and the heparan sulfate receptor. J Virol. 2022;96:e0054221.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

M A, T W, H S. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. The Journal of general virology [Internet]. 2008 [cited 2024 Jun 2];89. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18796721\/<\/a><\/p>\n

Nishimura Y, McLaughlin NP, Pan J, Goldstein S, Hafenstein S, Shimizu H, et al. The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and Heparan sulfate. PLoS Pathog. 2015;11:e1005184.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lalani SS, Anasir MI, Poh CL. Antiviral activity of silymarin in comparison with baicalein against EV-A71. BMC Complement Med Ther. 2020;20:97.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lalani S, Masomian M, Poh CL. Functional insights into Silymarin as an antiviral agent against enterovirus A71 (EV-A71). Int J Mol Sci. 2021;22:8757.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sun J, Ma X, Sun L, Zhang Y, Hao C, Wang W. Inhibitory effects and mechanisms of proanthocyanidins against enterovirus 71 infection. Virus Res. 2023;329:199098.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Falah N, Montserret R, Lelogeais V, Schuffenecker I, Lina B, Cortay J-C, et al. Blocking human enterovirus 71 replication by targeting viral 2A protease. J Antimicrob Chemother. 2012;67:2865\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chen B, Wang Y, Pei X, Wang S, Zhang H, Peng Y. Cellular caspase-3 contributes to EV-A71 2Apro-mediated down-regulation of IFNAR1 at the translation level. Virol Sin. 2020;35:64\u201372.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zheng W, Zhou Z, Rui Y, Ye R, Xia F, Guo F, et al. Traf3 activates STING-mediated suppression of EV-A71 and target of viral evasion. Signal Transduct Target Ther. 2023;8:79.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chen T, Grauffel C, Yang W-Z, Chen Y-P, Yuan HS, Lim C. Efficient strategy to design protease inhibitors: application to enterovirus 71 2A protease. ACS Bio Med Chem Au. 2022;2:437\u201349.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Liang Q, Shi S, Zhang Q, Wang Y, Ye S, Xu B. Etoposide targets 2A protease to inhibit enterovirus 71 replication. Microbiol Spectr. 2025;13:e0220024.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Binford SL, Maldonado F, Brothers MA, Weady PT, Zalman LS, Meador JW, et al. Conservation of amino acids in human rhinovirus 3 C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3 C protease inhibitor. Antimicrob Agents Chemother. 2005;49:619\u201326.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhang X, Song Z, Qin B, Zhang X, Chen L, Hu Y, et al. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antivir Res. 2013;97:264\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hayden FG, Turner RB, Gwaltney JM, Chi-Burris K, Gersten M, Hsyu P, et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother. 2003;47:3907\u201316.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lacroix C, George S, Leyssen P, Hilgenfeld R, Neyts J. The enterovirus 3 C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir. Antimicrob Agents Chemother. 2015;59:5814\u20138.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sripattaraphan A, Sanachai K, Chavasiri W, Boonyasuppayakorn S, Maitarad P, Rungrotmongkol T. Computational screening of newly designed compounds against coxsackievirus A16 and enterovirus A71. Molecules. 2022;27:1908.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dai W, Jochmans D, Xie H, Yang H, Li J, Su H, et al. Design, synthesis, and biological evaluation of peptidomimetic aldehydes as broad-spectrum inhibitors against enterovirus and SARS-CoV-2. J Med Chem. 2022;65:2794\u2013808.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xu B, Liu M, Ma S, Ma Y, Liu S, Shang L, et al. 4-Iminooxazolidin-2-One as a bioisostere of cyanohydrin suppresses EV71 proliferation by targeting 3Cpro. Microbiol Spectr. 2021;9:e0102521.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Qin B, Craven GB, Hou P, Chesti J, Lu X, Child ES, et al. Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3 C and SARS-CoV-2 main protease. Acta Pharm Sin B. 2022;12:3924\u201333.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wei Y, Hu D, Li D, Hu K, Zhang Q, Liu H, et al. Antiviral effects and mechanisms against EV71 of the novel 2-benzoxyl-phenylpyridine derivatives. Eur J Pharm Sci. 2023;186:106445.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yao C, Xi C, Hu K, Gao W, Cai X, Qin J, et al. Inhibition of enterovirus 71 replication and viral 3 C protease by Quercetin. Virol J. 2018;15:116.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cao Z, Ding Y, Ke Z, Cao L, Li N, Ding G, et al. Luteoloside acts as 3 c protease inhibitor of enterovirus 71 in vitro. PLoS ONE. 2016;11:e0148693.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin Y-J, Chang Y-C, Hsiao N-W, Hsieh J-L, Wang C-Y, Kung S-H, et al. Fisetin and Rutin as 3 c protease inhibitors of enterovirus A71. J Virol Methods. 2012;182:93\u20138.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Shi S, Xie L, Ma S, Xu B, An H, Ye S, et al. Computational and experimental studies of Salvianolic acid A targets 3 C protease to inhibit enterovirus 71 infection. Front Pharmacol. 2023;14:1118584.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lochaiyakun N, Srimanote P, Khantisitthiporn O, Thanongsaksrikul J. Novel anti-Enterovirus A71 compounds discovered by repositioning antivirals from the open-source MMV pandemic response box. Pharmaceuticals (Basel). 2024;17:785.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zuo J, Quinn KK, Kye S, Cooper P, Damoiseaux R, Krogstad P. Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob Agents Chemother. 2012;56:4838\u201344.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Bauer L, Manganaro R, Zonsics B, Hurdiss DL, Zwaagstra M, Donselaar T, et al. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2 C. PLoS Biol. 2020;18:e3000904.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tang Q, Xu Z, Jin M, Shu T, Chen Y, Feng L, et al. Identification of dibucaine derivatives as novel potent enterovirus 2 C helicase inhibitors: in vitro, in vivo, and combination therapy study. Eur J Med Chem. 2020;202:112310.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kejriwal R, Evans T, Calabrese J, Swistak L, Alexandrescu L, Cohen M, et al. Development of enterovirus antiviral agents that target the viral 2 C protein. ChemMedChem. 2023;18:e202200541.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Fang Y, Wang C, Wang C, Yang R, Bai P, Zhang X-Y, et al. Antiviral peptides targeting the helicase activity of enterovirus nonstructural protein 2 C. J Virol. 2021;95:e02324-20.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cui B, Yang G, Yan H, Wu S, Wang K, Wang H, et al. UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2 C. J Virol. 2024;98:e0133524.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xu C, Wang M, Cheng A, Yang Q, Huang J, Ou X, et al. Multiple functions of the nonstructural protein 3D in picornavirus infection. Front Immunol. 2024;15:1365521.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang X, Hu Z, Zhang W, Wu S, Hao Y, Xiao X, et al. Inhibition of lysosome-tethered Ragulator-Rag-3D complex restricts the replication of enterovirus 71 and Coxsackie A16. J Cell Biol. 2023;222:e202303108.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xu N, Yang J, Zheng B, Zhang Y, Cao Y, Huan C, et al. The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses. J Virol. 2020;94:e00204\u201320.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Gordon CJ, Walker SM, Tchesnokov EP, Kocincova D, Pitts J, Siegel DS, et al. Mechanism and spectrum of inhibition of a 4\u2019-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses. J Biol Chem. 2024;300:107514.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xu Y, Groaz E, Rihon J, Herdewijn P, Lescrinier E. Synthesis, antiviral activity, and computational study of \u03b2-d-xylofuranosyl nucleoside phosphonates. Eur J Med Chem. 2023;255:115379.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Nikonov OS, Chernykh ES, Garber MB, Nikonova EY. Enteroviruses. classification, diseases they cause, and approaches to development of antiviral drugs. Biochemistry (Moscow). 2017;82:1615\u201331.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lu W-W, Kung F-Y, Deng P-A, Lin Y-C, Lin C-W, Kung S-H. Development of a fluorescence resonance energy transfer-based intracellular assay to identify novel enterovirus 71 antivirals. Arch Virol. 2017;162:713\u201320.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lv X, Qiu M, Chen D, Zheng N, Jin Y, Wu Z. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antivir Res. 2014;109:30\u201341.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Liu J, Yang Y, Xu Y, Ma C, Qin C, Zhang L. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol J. 2011;8:483.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li Z, Ning S, Su X, Liu X, Wang H, Liu Y, et al. Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G. Nucleic Acids Res. 2018;46:11514\u201327.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang H, Zhong M, Li Y, Li K, Wu S, Guo T, et al. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity. Antiviral Res. 2019;165:23\u201333.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tang Q, Li S, Du L, Chen S, Gao J, Cai Y, et al. Emetine protects mice from enterovirus infection by inhibiting viral translation. Antivir Res. 2020;173:104650.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Davila-Calderon J, Patwardhan NN, Chiu L-Y, Sugarman A, Cai Z, Penutmutchu SR, et al. IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex. Nat Commun. 2020;11:4775.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dan X, Wan Q, Yi L, Lu J, Jiao Y, Li H, et al. Hsp27 responds to and facilitates enterovirus A71 replication by enhancing viral internal ribosome entry site-mediated translation. J Virol. 2019;93:e02322-18.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Periferakis A, Periferakis A-T, Troumpata L, Periferakis K, Scheau A-E, Savulescu-Fiedler I, et al. Kaempferol: a review of current evidence of its antiviral potential. Int J Mol Sci. 2023;24:16299.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Gunaseelan S, Wong KZ, Min N, Sun J, Ismail NKBM, Tan YJ, et al. Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection. Sci Transl Med. 2019;11:eaar5759.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Feferbaum-Leite S, Santos IA, Grosche VR, da Silva GCD, Jardim ACG. Insights into enterovirus A-71 antiviral development: from natural sources to synthetic nanoparticles. Arch Microbiol. 2023;205:334.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

He J, Xiong W, Zhao L, Liu B, Huang Y. Anti-\u03b1-glucosidase, anti-proliferative and anti-enterovirus 71 activity of secondary metabolites identified from Grifola frondosa. Plant Foods Hum Nutr. 2023;78:783\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cao Y, Lei E, Li L, Ren J, He X, Yang J, et al. Antiviral activity of Mulberroside C against enterovirus A71 in vitro and in vivo. Eur J Pharmacol. 2021;906:174204.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Olasunkanmi OI, Fei Y, Avala Ntsigouaye J, Yi M, Wang Y, Liu J et al. Antiviral activity of trans-Hexenoic acid against coxsackievirus B and enterovirus A71. Antimicrob Agents Chemother. 2023;67(3):e00868\u201322.<\/p>\n

Lin W-Y, Yu Y-J, Jinn T-R. Evaluation of the virucidal effects of Rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study. Virol J. 2019;16:94.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhang Q-Y, Li J-Q, Li Q, Zhang Y, Zhang Z-R, Li X-D, et al. Identification of Fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening. Virol Sin. 2024;39(2):301\u20138.<\/p>\n

Zou X, Wu J, Gu J, Shen L, Mao L. DNA aptamer against EV-A71 VP1 protein: selection and application. Virol J. 2021;18:164.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin Z, Li Y, Xu T, Guo M, Wang C, Zhao M, et al. Inhibition of enterovirus 71 by selenium nanoparticles loaded with SiRNA through Bax signaling pathways. ACS Omega. 2020;5:12495\u2013500.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Rattanapisit K, Chao Z, Siriwattananon K, Huang Z, Phoolcharoen W. Plant-produced anti-Enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection. Plants (Basel). 2019;8:560.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ang WX, Tan SH, Wong KT, Perera D, Kuppusamy UR, Ong KC. Antiviral activity of povidone-iodine gargle and mouthwash solution against enterovirus A71, coxsackieviruses A16, A10 and A6. Trop Biomed. 2024;41:241\u201350.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Roux H, Touret F, Coluccia A, Khoumeri O, Di Giorgio C, Majdi C, et al. New potent EV-A71 antivirals targeting capsid. Eur J Med Chem. 2024;276:116658.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pei Z, Wang H, Zhao Z, Chen X, Huan C, Zhang W. Chemokine PF4 inhibits EV71 and CA16 infections at the entry stage. J Virol. 2022;96:e0043522.<\/p>\n

PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yi K, Xie L, Li Y. Monoclonal antibody targeting a conserved N-terminal epitope on 2apro of enteroviruses. Monoclon Antib Immunodiagn Immunother. 2019;38:220\u20133.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hu Y, Kitamura N, Musharrafieh R, Wang J. Discovery of potent and broad-spectrum pyrazolopyridine-containing antivirals against enteroviruses D68, A71, and coxsackievirus B3 by targeting the viral 2 C protein. J Med Chem. 2021;64:8755\u201374.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Musharrafieh R, Kitamura N, Hu Y, Wang J. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold. Bioorg Chem. 2020;101:103981.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li P, Wu S, Xiao T, Li Y, Su Z, Wei W, et al. Design, synthesis, and evaluation of a novel macrocyclic anti-EV71 agent. Bioorg Med Chem. 2020;28:115551.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li Z, Cui B, Liu X, Wang L, Xian Q, Lu Z, et al. Virucidal activity and the antiviral mechanism of acidic polysaccharides against enterovirus 71 infection in vitro. Microbiol Immunol. 2020;64:189\u2013201.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Liu M, Xu B, Ma Y, Shang L, Ye S, Wang Y. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3 C protease. Antivir Res. 2021;192:105102.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3 C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A. 1999;96:11000\u20137.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tijsma A, Franco D, Tucker S, Hilgenfeld R, Froeyen M, Leyssen P, et al. The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob Agents Chemother. 2014;58:6990\u20132.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Le TTV, Do P-C. Molecular docking study of various Enterovirus-A71 3 C protease proteins and their potential inhibitors. Front Microbiol. 2022;13:987801.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sun J, Yogarajah T, Lee RCH, Kaur P, Inoue M, Tan YW, et al. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications. Sci Rep. 2020;10:8159.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ye W, Yao M, Dong Y, Ye C, Wang D, Liu H, et al. Remdesivir (GS-5734) impedes enterovirus replication through viral RNA synthesis inhibition. Front Microbiol. 2020;11:1105.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Janissen R, Woodman A, Shengjuler D, Vallet T, Lee K-M, Kuijpers L, et al. Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses. Mol Cell. 2021;81:4467\u2013e44807.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Huang X, Li J, Hong Y, Jiang C, Wu J, Wu M, et al. Antiviral effects of the petroleum ether extract of Tournefortia sibirica L. against enterovirus 71 infection in vitro and in vivo. Front Pharmacol. 2022;13:999798.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hu J, Wang H, Yang L, Wu S, Li Y, Li Y, et al. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids. J Glob Antimicrob Resist. 2022;31:371\u20138.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tsai F-J, Lin C-W, Lai C-C, Lan Y-C, Lai C-H, Hung C-H, et al. Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem. 2011;128:312\u201322.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cao Y, Lei E, Wang X, Qi X, Li L, Ren J, et al. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo. Antivir Res. 2021;195:105091.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Doctor KZ, Gilmour E, Recarte M, Beatty TR, Shifa I, Stangel M, et al. Automated SSHHPS analysis predicts a potential host protein target common to several neuroinvasive (+)ssRNA viruses. Viruses. 2023;15:542.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin D, Dong X, Xiao X, Xiang Z, Lei X, Wang J. Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication. Antivir Res. 2023;220:105761.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kobayashi K, Koike S. Cellular receptors for enterovirus A71. J Biomed Sci. 2020;27:23.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Feng Q, Zhou H, Zhang X, Liu X, Wang J, Zhang C, et al. Acarbose, as a potential drug, effectively blocked the dynamic metastasis of EV71 from the intestine to the whole body. Infect Genet Evol. 2020;81:104210.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhu G, Wu C, Wang Q, Deng D, Lin B, Hu X, et al. Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71. Antivir Res. 2023;211:105553.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hu K, Onintsoa Diarimalala R, Yao C, Li H, Wei Y. EV-A71 mechanism of entry: receptors\/co-receptors, related pathways and inhibitors. Viruses. 2023;15:785.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zarif F, Anasir MI, Koh JX, Chew M-F, Poh CL. Stability and antiviral activity of SP40 peptide in human serum. Virus Res. 2021;303:198456.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010;1:CD006117.<\/p>\n

Tseng K-C, Hsu B-Y, Ling P, Lu W-W, Lin C-W, Kung S-H. Antidepressant sertraline is a broad-spectrum inhibitor of enteroviruses targeting viral entry through neutralization of endolysosomal acidification. Viruses. 2022;14:109.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Vishakantegowda G, Hwang A, Chakrasali D, Jung P, Lee E, Shin J-Y. Highly potent and selective phosphatidylinositol 4-kinase III\u03b2 inhibitors as broad-spectrum anti-rhinoviral agents. RSC Med Chem. 2024;15:704\u201319.<\/p>\n

CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Arita M. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol Immunol. 2014;58:239\u201356.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Roulin PS, L\u00f6tzerich M, Torta F, Tanner LB, van Kuppeveld FJM, Wenk MR, et al. Rhinovirus uses a phosphatidylinositol 4-phosphate\/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe. 2014;16:677\u201390.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Luo Z, Liang Y, Tian M, Ruan Z, Su R, Shereen MA, et al. Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication. J Med Virol. 2023;95:e28527.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li X, Zhang J, Xiao Y, Song H, Li Y, Li W, et al. Chemoproteomics enables identification of coatomer subunit zeta-1 targeted by a small molecule for enterovirus A71 inhibition. MedComm. 2024;5:e587.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang Y, Cao L, Gao H, Wu Y, Wang Y, Fang F, et al. Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors. J Med Chem. 2019;62:4056\u201373.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang Q, Wu C, Zhu G, Ren F, Lin B, Huang R, et al. ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway. Antivir Res. 2023;209:105498.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xu L, Su W, Jin J, Chen J, Li X, Zhang X, et al. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses. 2014;6:2778\u201395.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wu M, Wan Q, Dan X, Wang Y, Chen P, Chen C, et al. Targeting ser78 phosphorylation of Hsp27 achieves potent antiviral effects against enterovirus A71 infection. Emerg Microbes Infect. 2024;13:2368221.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Van Der Schaar HM, Dorobantu CM, Albulescu L, Strating JRPM, Van Kuppeveld FJM. Fat(al) attraction: picornaviruses usurp lipid transfer at membrane contact sites to create replication organelles. Trends Microbiol. 2016;24:535\u201346.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yang X, Chen J, Lu Z, Huang S, Zhang S, Cai J, et al. Enterovirus A71 utilizes host cell lipid \u03b2-oxidation to promote its replication. Front Microbiol. 2022;13:961942.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xie H, Yang E, Wang C, Peng C, Ji L. Targeting HDAC11 activity by FT895 restricts EV71 replication. Virus Res. 2023;330:199108.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Huang L, Yue J. The interplay of autophagy and enterovirus. Semin Cell Dev Biol. 2020;101:12\u20139.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hao T, Li Y, Fan S, Li W, Wang S, Li S, et al. Design, synthesis and pharmacological evaluation of a novel mTOR-targeted anti-EV71 agent. Eur J Med Chem. 2019;175:172\u201386.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

You Q, Wu J, Lyu R, Cai Y, Jiang N, Liu Y, et al. 6-thioguanine inhibits EV71 replication by reducing BIRC3-mediated autophagy. BMC Microbiol. 2025;25:53.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Li H, Bai Z, Li C, Sheng C, Zhao X. EV71 infection induces cell apoptosis through ROS generation and SIRT1 activation. J Cell Biochem. 2020;121:4321\u201331.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cui G, Wang H, Yang C, Zhou X, Wang J, Wang T, et al. Berberine prevents lethal EV71 neurological infection in newborn mice. Front Pharmacol. 2022;13:1027566.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chen H, Ning Z, Liu X, Su J, Chen D, Lai J, et al. Ebselen inhibits enterovirus A71-induced apoptosis through reactive oxygen species-mediated signaling pathway. Mol Biol Rep. 2023;50:2991\u20133000.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhao D, Guo X, Lin B, Huang R, Li H, Wang Q, et al. Magnolol against enterovirus 71 by targeting Nrf2-SLC7A11-GSH pathway. Biomed Pharmacother. 2024;176:116866.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Song J-H, Mun S-H, Yang H, Kwon YS, Kim S-R, Song M-Y, et al. Antiviral mechanisms of Saucerneol from Saururus chinensis against enterovirus A71, coxsackievirus A16, and coxsackievirus B3: role of mitochondrial ROS and the STING\/TKB-1\/IRF3 pathway. Viruses. 2023;16:16.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Masomian M, Lalani S, Poh CL. Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71). Molecules. 2021;26:6576.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Bailly B, Gorle AK, Dirr L, Malde AK, Farrell NP, Berners-Price SJ, et al. Platinum complexes act as shielding agents against virus infection. Chem Commun. 2021;57:4666\u20139.<\/p>\n

CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Niu Q, Zhou H, Ma X, Jiang Y, Liu C, Wang W, et al. Anti-enterovirus 71 activity of native fucosylated chondroitin sulfates and their derivatives. Carbohydr Polym. 2024;346:122657.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Quan J, Zhang X, Ding Y, Li S, Qiu Y, Wang R, et al. Cucurbit[7]uril as a broad-spectrum antiviral agent against diverse RNA viruses. Virol Sin. 2021;36:1165\u201376.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tan JK, Chen R, Lee RCH, Li F, Dai K, Zhou G-C, et al. Discovery of novel Andrographolide derivatives as antiviral inhibitors against human enterovirus A71. Pharmaceuticals (Basel). 2022;15:115.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ge Q, Zhang Z, Cao Z, Wu D, Xu C, Yao J, et al. Exploration of the in vitro antiviral effects and the active components of Changyanning tablets against enterovirus 71. Drug Des Devel Ther. 2024;18:651\u201365.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Gao C, Wen C, Li Z, Lin S, Gao S, Ding H, et al. Fludarabine inhibits infection of Zika virus, SFTS phlebovirus, and enterovirus A71. Viruses. 2021;13:774.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Huang L, Fu Q, Dai J-M, Yan B-C, Wang D, Puno P-T, et al. High-content screening of diterpenoids from Isodon species as autophagy modulators and the functional study of their antiviral activities. Cell Biol Toxicol. 2021;37:695\u2013713.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhou F, Wan Q, Lu J, Chen Y, Lu G, He M-L. Pim1 impacts enterovirus A71 replication and represents a potential target in antiviral therapy. iScience. 2019;19:715\u201327.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Shi H, Liu S, Tan Z, Yin L, Zeng L, Liu T, et al. Proteomic and metabonomic analysis uncovering enterovirus A71 reprogramming host cell metabolic pathway. Proteomics. 2023;23:2200362.<\/p>\n

CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Salerno M, Varricchio C, Bevilacqua F, Jochmans D, Neyts J, Brancale A, et al. Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71. Eur J Med Chem. 2023;246:114942.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Du N, Li X-H, Bao W-G, Wang B, Xu G, Wang F. Resveratrol\u2013loaded nanoparticles inhibit enterovirus 71 replication through the oxidative stress\u2013mediated ERS\/autophagy pathway. Int J Mol Med. 2019;44:737\u201349.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhao X, Li C, Chiu MC, Qiao R, Jiang S, Wang P, et al. Rock1 is a novel host dependency factor of human enterovirus A71: implication as a drug target. J Med Virol. 2022;94:5415\u201324.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Zhang X, Hao J, Sun C, Du J, Han Q, Li Q. Total astragalosides decrease apoptosis and pyroptosis by inhibiting enterovirus 71 replication in gastric epithelial cells. Exp Ther Med. 2022;23:237.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hu B, Chik KK-H, Chan JF-W, Cai J-P, Cao H, Tsang JO-L, et al. Vemurafenib inhibits enterovirus A71 genome replication and virus assembly. Pharmaceuticals (Basel). 2022;15:1067.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang H, Chen F, Wang S, Li Y, Liu T, Li Y, et al. Evaluation and mechanism study of Pien tze Huang against EV-A71 infection. Front Pharmacol. 2023;14:1251731.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kim S-H, Lee J, Jung YL, Hong A, Nam S-J, Lim B-K. Salvianolic acid B inhibits Hand-Foot-Mouth disease enterovirus 71 replication through enhancement of AKT signaling pathway. J Microbiol Biotechnol. 2020;30:38\u201343.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xu T, Li Y, Wu H, Chen H, Wu H, Guo M, et al. The inhibition of enterovirus 71 induced apoptosis by Durvillaea antarctica through P53 and STAT1 signaling pathway. J Med Virol. 2021;93:3532\u20138.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hao J, Zhang X, Hu R, Lu X, Wang H, Li Y, et al. Metabolomics combined with network pharmacology reveals a role for Astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling. J Transl Med. 2024;22:555.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Xia Z, Wang H, Chen W, Wang A, Cao Z. Scorpion venom antimicrobial peptide derivative BmKn2-T5 inhibits enterovirus 71 in the early stages of the viral life cycle in vitro. Biomolecules. 2024;14:545.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ferreira FJN, Carneiro AS. Ai-driven drug discovery: a comprehensive review. ACS Omega. 2025;10:23889\u2013903.<\/p>\n

PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dai W, Bi J, Li F, Wang S, Huang X, Meng X, et al. Antiviral efficacy of flavonoids against enterovirus 71 infection in vitro and in newborn mice. Viruses. 2019;11:625.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dewanjee S, Chakraborty P, Bhattacharya H, Singh SK, Dua K, Dey A, et al. Recent advances in flavonoid-based nanocarriers as an emerging drug delivery approach for cancer chemotherapy. Drug Discov Today. 2023;28:103409.<\/p>\n

CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n","protected":false},"excerpt":{"rendered":"Pallansch MA, Oberste MS, Whitton J. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM,…\n","protected":false},"author":2,"featured_media":253016,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[149749,64,63,1730,149748,137,149750,7474,149751],"class_list":{"0":"post-253015","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-antiviral-target","9":"tag-au","10":"tag-australia","11":"tag-drugs","12":"tag-enterovirus-71","13":"tag-health","14":"tag-lifecycle","15":"tag-virology","16":"tag-virus-components"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/253015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=253015"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/253015\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/253016"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=253015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=253015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=253015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}